Pharmaceutical & Sterile Gloves: The GMP Annex 1 Sourcing Guide for Procurement Teams (2026)

1. Why Glove Selection Is a Compliance Decision, Not a Purchasing One

In most industrial categories a glove is a consumable. In pharmaceutical manufacturing it is a direct product-contact surface. The operator's gloved hand is, in a Grade A filling line, frequently the closest non-product surface to an open vial. That single fact changes everything about how the item should be bought.

Regulators have made this explicit. Human-borne contamination remains the dominant root cause in sterility assurance failures, and glove contact is repeatedly cited in aseptic process simulation deviations and in EudraGMDP non-compliance reports. When an inspector opens a media fill investigation, the question is rarely "did you buy a good glove" — it is "can you show me the specification, the qualification data, the incoming inspection record and the sterilisation validation for the glove that was on that operator's hand".

The practical consequence for procurement is uncomfortable but simple: a glove that cannot be documented cannot be used, regardless of how well it performs. Many buyers discover this only after a first shipment arrives with a one-page certificate that lists nothing but "passed visual inspection". This guide is written to prevent that.

2. EU GMP Annex 1: What Changed for Glove Buyers

The revised EU GMP Annex 1 on the Manufacture of Sterile Medicinal Products was published in August 2022 and became applicable on 25 August 2023, with a single deferred clause on lyophiliser transfer taking effect a year later. It replaced a 2008 document that said comparatively little about gloves. The 2022 text is far more prescriptive, and three changes matter directly to procurement.

2.1 The Contamination Control Strategy (CCS)

Annex 1 requires a documented, site-wide Contamination Control Strategy that identifies all contamination sources and the controls applied to each. Gloves are named as part of the personnel and gowning control set. This means your glove specification, supplier qualification and change-frequency rules must be traceable from the CCS. A purchase order that simply says "nitrile gloves, sterile, size M" is not a control — and auditors will say so.

2.2 Explicit sterile glove requirement for Grade A/B

The revision states that sterile gloves must be worn for Grade A and Grade B activities and that they must be disinfected regularly during operations, with disinfection frequency justified. It also requires that gloves be changed at defined intervals and immediately if integrity is compromised. Practically, this converts glove consumption from an estimate into a calculated figure your supplier must be able to sustain.

2.3 Glove integrity as monitored data

Annex 1 reinforces glove-print monitoring for Grade A/B operators (typically five-finger contact plates after critical interventions) and, separately, requires integrity testing of isolator and RABS glove ports. The two are different items — operator gloves and isolator glove sleeves — and buyers frequently conflate them. This guide covers operator gloves; isolator gauntlets are a separate qualification exercise with their own leak-test regime.

3. Cleanroom Grades and Which Glove Belongs Where

EU GMP grades and ISO 14644-1 classes describe the same physical environment with different vocabulary. Buyers need both because suppliers quote in ISO classes while quality units write specifications in GMP grades.

Two errors dominate. The first is buying sterile gloves for Grade C and D areas — a pure cost leak that can add $40,000–$90,000 a year at a mid-size site with 200 gowned staff. The second is the opposite: buying a "cleanroom" glove for Grade B because the datasheet mentions ISO Class 5 packaging. Cleanroom packaging is not sterility. If the pouch does not carry a sterilisation lot number and a radiation indicator, it is not a sterile product.

4. Sterile vs Cleanroom: SAL 10⁻⁶ and Sterilisation Validation

"Sterile" in a regulatory sense means a Sterility Assurance Level of 10⁻⁶ — a probability of not more than one viable micro-organism in one million sterilised units. That number is achieved by dose-setting, not by testing every glove. This is why the validation package, not the sterility certificate, is the document that matters.

For nitrile and polyisoprene gloves, gamma irradiation at a validated 25 kGy dose is the default in 2026. Roughly nine out of ten sterile glove SKUs on the market use it. E-beam is growing where turnaround time matters more than pallet density. Ethylene oxide has largely fallen out of favour for gloves because of residue testing burden and tightening EU restrictions.

5. Material Comparison: Nitrile, Neoprene, Polyisoprene, Latex

Material choice in pharma is driven by three things that rarely appear in industrial glove selection: protein/allergen risk, chemotherapy drug permeation, and compatibility with the disinfectant sprayed onto the glove several times an hour.

The direction of travel is clear. Natural rubber latex has been displaced across most EU and North American sterile sites because of Type I hypersensitivity liability, and vinyl has effectively no place inside a classified area handling active pharmaceutical ingredient. Nitrile has become the volume default; polyisoprene survives where an operator needs to work an hour-long intervention with maximum tactile feedback and is willing to pay roughly double.

5.1 The IPA question buyers forget

Aseptic operators spray 70% IPA on their gloves continuously — in some filling suites, more than 40 times per shift. Repeated IPA exposure degrades some film chemistries and, more importantly, can leach plasticisers and increase particle shedding. When you qualify a glove, ask the supplier for post-IPA-exposure data: tensile retention after 30 minutes of cumulative IPA contact, and particle count after the same exposure. Very few suppliers volunteer this. The ones who have it are usually the ones worth qualifying.

6. The Nine Specifications That Belong in Your RFQ

A pharmaceutical glove RFQ that lists only material, size and quantity will produce quotations that cannot be compared. These nine parameters make quotes comparable and protect you at incoming inspection.

Add a tenth line if you handle cytotoxics: permeation testing to ASTM D6978 against your actual drug list, with breakthrough time reported per compound. A generic "chemo tested" claim without the compound list is worthless — permeation is drug-specific, and carmustine will defeat films that hold cyclophosphamide for four hours.

7. The Lot Documentation Pack You Must Demand

Write this into the quality agreement, not the purchase order. Purchase orders get superseded; quality agreements get audited.

1. Certificate of Analysis per lot — AQL results with sample size and accept/reject numbers, force at break, dimensions, powder residue.
2. Certificate of Irradiation — minimum and maximum absorbed dose in kGy, dosimetry system, irradiation facility name and address, sterilisation lot number cross-referenced to the production lot.
3. ISO 11137-2 validation summary + latest two dose audits — including method used (VDmax₂₅ is most common) and audit dates.
4. Bioburden report to ISO 11737-1 — pre-sterilisation bioburden per glove, sampled at defined frequency.
5. Sterility test to ISO 11737-2 (where performed) or a justified statement of parametric release.
6. Endotoxin, particulate, NVR and ionic extractables per lot or per validated frequency.
7. Biocompatibility to ISO 10993-1/-5/-10 — cytotoxicity, irritation, sensitisation.
8. EU Declaration of Conformity with notified body number, plus classification under EU MDR 2017/745 and/or PPE Regulation 2016/425 as applicable.
9. Shelf life justification — real-time or accelerated ageing data supporting the expiry date printed on the pouch.

8. Double-Gloving, Change Frequency and Disinfection

Annex 1 requires defined change intervals and justified disinfection frequency. Most sites converge on a similar operating model, which is useful for forecasting volume.

Run this model against headcount and shift pattern before you send an RFQ. A 200-person site with 120 gowned operators typically lands between 480,000 and 720,000 pairs a year across all grades, with roughly 20–25% of that volume being sterile. That split is what determines whether sterile MOQ economics work for you.

8.1 Why double-gloving is not just redundancy

The outer glove is the sacrificial, frequently disinfected and frequently changed layer. The inner glove maintains the sterile barrier during the change itself, so the operator never exposes bare skin inside the critical zone. This matters for procurement because the two layers are usually different SKUs: the inner is typically a longer-cuff sterile glove sized to the gown, the outer a textured-fingertip sterile glove one half-size larger. Ordering a single SKU for both roles is a common and expensive mistake — operators end up double-donning the same glove, which reduces dexterity and increases intervention time.

9. Packaging and Aseptic Transfer into Grade A/B

The best glove in the world fails if it cannot be brought into the cleanroom without contaminating it. Packaging is a technical specification, not a marketing detail.

• Double or triple bagging. Each layer is removed at a grade transition. Triple-bagged product is standard for direct Grade A/B introduction; double-bagged is normally acceptable when entering via Grade C with a sporicidal wipe-down step.
• Sporicidal / VHP compatibility. The outer film must tolerate your actual disinfectant — peracetic acid blends and hydrogen peroxide vapour degrade some laminates. Request compatibility data for your named product, not a generic statement.
• Peel-open presentation. Sterile gloves should be presented in a folded inner wallet with cuffs turned back so the operator can don without touching the outer surface. Poor wallet design measurably increases donning contamination.
• Cleanroom-packed at source. Gloves should be washed, dried and packed inside an ISO Class 5–7 environment. Ask which class, and ask for the most recent room certification.
• Labelling. Lot number, sterilisation lot number, expiry date, radiation indicator dot, size, and a machine-readable code. Barcode compatibility with your warehouse system saves real time at goods-in.
• Case configuration. Typically 50 pairs/inner box, 200–400 pairs/carton. Confirm carton dimensions early — pharma warehouses often have narrow-aisle constraints that make an otherwise cheaper carton format unusable.

10. Real Cost Model: Why Unit Price Is the Wrong Metric

Sterile glove tenders are frequently decided on FOB unit price, which is the least informative number in the file. The following model reflects a 20,000-pair sterile lot shipped FOB Qingdao.

Two observations that change negotiations. First, irradiation is a step function: it is priced by pallet position, so a 6,000-pair order and a 20,000-pair order can carry almost the same irradiation charge, which is why the effective sterile MOQ is far above the manufacturing MOQ. Second, the lot testing pack is fixed per lot, not per pair — splitting an annual requirement into six small lots instead of two large ones can add 4–6 cents per pair in pure documentation cost.

11. Regional Regulatory Requirements

Gloves sold into pharmaceutical use cross two regulatory worlds — medical device and PPE — and the answer differs by market and by intended use.

A recurring trap: a supplier holds a CE certificate under the PPE Regulation only, and the buyer assumes it covers medical use. It does not. A sterile glove used in pharmaceutical manufacture where the glove is a product-contact surface will normally require the medical device route in the EU, and a PPE-only Declaration of Conformity will be a finding. Read the DoC and check which regulation it cites — it takes thirty seconds and saves a recall.

12. Sourcing Checklist and Supplier Qualification

Use this as a gate sequence. Do not move to the next stage until the previous one passes.

1. Paper screen. ISO 13485 certificate, ISO 9001, EU DoC citing the correct regulation, notified body number verifiable in NANDO.
2. Specification alignment. Supplier confirms every line of Table 5 in writing, with test methods named. Any "equivalent method" claim must be justified.
3. First article + documentation dry run. Order 200–500 pairs with the complete lot pack. Grade the paperwork as strictly as the product.
4. Physical qualification. Independent AQL verification, particulate and endotoxin retesting at your own lab or a third party. Budget roughly $1,200–$2,500 for a full independent re-test.
5. Operator trial. Ten operators, two weeks, structured feedback on donning, tactile feel, IPA tolerance and cuff integrity. Operator rejection after go-live is the most expensive failure mode.
6. On-site or remote audit. Focus on the cleanroom packing hall, water system, bioburden control and the sterilisation subcontractor relationship. The glove factory is rarely the irradiator — audit both.
7. Quality agreement. Change control clause is the critical line: no change to compound, former, packing hall, sterilisation facility or dose without prior written approval.
8. Dual sourcing. Qualify a second supplier before you need one. Single-sourced sterile gloves is a supply-risk finding in its own right.

12.1 Where Expedition Safety fits

Expedition Safety manufactures powder-free nitrile examination and cleanroom-packed gloves from our facility in Shandong, China, with cleanroom packing, full EN 455 test data and CE documentation. Standard MOQ is 6,000 pairs per style, size and colour, FOB Qingdao, with 20–25 day lead times for cleanroom-packed non-sterile product. Terminally sterilised (gamma, 25 kGy) versions are produced through validated partner irradiation facilities with full ISO 11137 documentation, on a 35–45 day lead time and a practical 20,000-pair sterilisation lot. If your requirement is Grade C/D cleanroom volume with occasional sterile call-offs, that is the profile we serve best — and we will say so plainly if a requirement sits outside it.

For a wider view of certification logic across our range, see the EU PPE Regulation 2016/425 compliance guide, the glove QC and AQL inspection guide, and our 2026 safety glove sourcing guide. Full specifications are on the product catalogue, commercial terms on the wholesale page, and common buyer questions on the FAQ.

Frequently Asked Questions